Status:
COMPLETED
Non-invasive Hemoglobin Monitoring in Congenital Heart Diseased Children
Lead Sponsor:
Cairo University
Conditions:
Congenital Heart Disease
Eligibility:
All Genders
1-8 years
Brief Summary
The investigators will evaluate the accuracy of non-invasive hemoglobin monitor (Sp-Hb) compared to traditional laboratory hemoglobin (Lab-Hb) in children with congenital heart disease. The investigat...
Detailed Description
Blood hemoglobin is measured daily in clinical practice. Laboratory measurement (Lab-Hb) of is the gold standard for assessment of blood hemoglobin. Recently, non-invasive monitors had been introduced...
Eligibility Criteria
Inclusion
- infants and children less than 8 years
- with congenital heart disease
Exclusion
- refusal of the patient surrogate to share in the study
Key Trial Info
Start Date :
February 20 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 10 2019
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT03248830
Start Date
February 20 2018
End Date
September 10 2019
Last Update
October 1 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo University
Cairo, Egypt